Psychotropic use in community residential care facilities: A prospective cohort study

American Journal Geriatric Pharmacotherapy

Volumn 4, Issue 3, 2006, Pages 227-235

  Lakey, Susan L ^a   Gray, Shelly L ^a   Sales, Anne E B ^a,b   Sullivan, Jean ^b   Hedrick, Susan C ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

cohort study; geriatrics; psychotropic drugs; residential facilities

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUSPIRONE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLONAZEPAM; CLORAZEPATE; DIAZEPAM; DOXEPIN; FLURAZEPAM; HALAZEPAM; HALOPERIDOL; IMIPRAMINE; LONG ACTING DRUG; NEUROLEPTIC AGENT; PAROXETINE; PRAZEPAM; PSYCHOTROPIC AGENT; QUAZEPAM; RISPERIDONE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THIORIDAZINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZOLPIDEM;

AGED; ARTICLE; BEHAVIOR DISORDER; COHORT ANALYSIS; COMMUNITY CARE; DAILY LIFE ACTIVITY; DATA BASE; DEMOGRAPHY; DEPRESSION; DRUG USE; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEMORY DISORDER; MENTAL DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; RESIDENTIAL CARE; SCORING SYSTEM; SELF REPORT; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; DRUG UTILIZATION; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; NURSING HOMES; NURSING STAFF; PERSONNEL STAFFING AND SCHEDULING; POLYPHARMACY; PROSPECTIVE STUDIES; PSYCHOTROPIC DRUGS; SOCIOECONOMIC FACTORS;

EID: 33751001059     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2006.09.010     Document Type: Article

References (33)

1. Aud M.A., and Rantz M.J. Quality concerns in assisted living facilities. J Nurs Care Qual. 19 (2004) 8-9
2. Kissam S., Gifford D.R., Mor V., and Patty G. Admission and continued-stay criteria for assisted living facilities. J Ant Geriatr Soc. 51 (2003) 1651-1654
3. Spore D., Mor V., Hiris J., et al. Psychotropic use among older residents of board and care facilities. J Am Geriatr Soc. 43 (1995) 1403-1409
4. Available at: [eh][ir]http://www.aspe.hhs.gov/daltcp/reports/hshpes.htm. Hawes C., and Phillips C.D. High Service or High Privacy Assisted Living Facilities, Their Residents and Staff: Results from a National Survey. Accessed October 16, 2005 (2000)
5. Avorn J., Dreyer P., Connelly K., and Soumerai S.B. Use of psychoactive medication and the quality of care in rest homes. Findings and policy implications of a statewide study. N Engl J Med. 320 (1989) 227-232
6. Gruber-Baldini A.L., Boustani M., Sloane P.D., and Zimmerman S. Behavioral symptoms in residential care/assisted living facilities: Prevalence, risk factors, and medication management. J Am Geriatr Soc. 52 (2004) 1610-1617
7. Williams B.R., Nichol M.B., Lowe B., et al. Medication use in residential care facilities for the elderly. Ann Pharrnacother. 33 (1999) 149-155
8. Spore D., Mor V., Larrat E.P., et al. Regulatory environment and psychotropic use in board-and-care facilities: Results of a 10-state study. J Gerontol A Biol Sci Med Sci. 51 (1996) 131-141
9. Aparasu R.R., Mort J.R., and Brandt H. Psychotropic prescription use by community-dwelling elderly in the United States. J Am Geriatr Soc. 51 (2003) 671-677
10. Briesacher B.A., Limcangco M.R., Simoni-Wastila L., et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med. 165 (2005) 1280-1285
11. Tobias D.E., and Sey M. General and psychotherapeutic medication use in 328 nursing facilities: A year 2000 national survey. Consult Pharrn 16 (2001) 54-64
12. quiz 44. Mitty E.L. Policy perspectives: Assisted living and the role of nursing. Am J Nurs. 103 (2003) 3213
13. Reinhard S., Young H., Kane R., and Quinn W. Final report: Nurse delegation of medication administration for elders in assisted living (2003), American Nurses Foundation, Baltimore, Md
14. Svarstad B.L., and Mount J.K. Nursing home resources and tranquilizer use among the institutionalized elderly. J Am Geriatr Soc. 39 (1991) 869-875
15. Short R.I., Fought R.L., and Ray W.A. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA 271 (1994) 358-362
16. Hedrick S.C., Sales A.E., Sullivan J.H., et al. Resident outcomes of Medicaid-funded community residential care. Gerontologist 43 (2003) 473-482
17. Ware Jr. J., Kosinski M., and Keller S.D. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care. 34 (1996) 220-233
18. Katzman R., Brown T., Fuld P., et al. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry 140 (1983) 734-739
19. Teri L., Truax P., Logsdon R., et al. Assessment of behavioral problems in dementia: The revised memory and behavior problems checklist. Psychol Aging. 7 (1992) 622-631
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Text Revision (DSM-IV-TR). 4th ed. (2000), American Psychiatric Association, Washington, DC
21. McEvoy J.K. American Hospital Formulary Service (AHFS) Drug Information (2001), American Society of Health-System Pharmacists, Inc, Bethesda, Md
22. James S.P., and Mendelson W.B. The use of trazodone as a hypnotic: A critical review. J Clin Psychiatry 65 (2004) 752-755
23. Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 157 (1997) 1531-1536
24. Fick D.M., Cooper J.W., Wade W.E., et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med. 163 (2003) 2716-2724
25. Little R.J., and Rubin D.B. Statistical Analysis with Missing Data (1987), John Wiley & Sons, New York, NY
26. Arthur A., Matthews R., Jagger C., and Lindesay J. Factors associated with antidepressant treatment in residential care: Changes between 1990 and 1997. Int J Geriatr Psychiatry 17 (2002) 54-60
27. Available at: [eh][ir]http:// www.fda.gov/cder/drug/infopage/antipsychotics/ default.htm. Atypical Antipsychotic Drugs Information. US Food and Drug Administration Web site. Accessed (October 16, 2005)
28. Wang P.S., Schneeweiss S., Avorn J., et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 353 (2005) 2335-2341
29. Tamblyn R., Abrahamowicz M., du Berger R., et al. A 5year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc. 53 (2005) 233-241
30. Gray S.L., LaCroix A.Z., Hanlon J.T., et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc. 54 (2006) 224-230
31. Wang P.S., Bohn R.L., Glynn R.J., et al. Zolpidem use and hip fractures in older people. J Am Geriatr Soc. 49 (2001) 1685-1690
32. Lindesay J., Matthews R., and Jagger C. Factors associated with antipsychotic drug use in residential care: Changes between 1990 and 1997. Int J Geriatr Psychiatry 18 (2003) 511-519
33. Bronskill S.E., Anderson G.M., Sykora K., et al. Neuroleptic drug therapy in older adults newly admitted to nursing homes: Incidence, dose, and specialist contact. J Am Geriatr Soc. 52 (2004) 749-755